Takeda Pharmaceutical
TAK
#469
Rank
HK$383.95 B
Marketcap
HK$115.38
Share price
2.49%
Change (1 day)
15.90%
Change (1 year)

Market capitalization of Takeda Pharmaceutical (TAK)

Market cap: HK$383.95 Billion

As of December 2025 Takeda Pharmaceutical has a market cap of HK$383.95 Billion. This makes Takeda Pharmaceutical the world's 469th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Takeda Pharmaceutical from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$383.95 B17.45%
2024HK$326.91 B-7.09%
2023HK$351.87 B-7.14%
2022HK$378.95 B13.78%
2021HK$333.04 B-24.52%
2020HK$441.26 B-8.57%
2019HK$482.61 B134.93%
2018HK$205.42 B-40.64%
2017HK$346.04 B36.98%
2016HK$252.62 B-17.64%
2015HK$306.73 B19.76%
2014HK$256.11 B-9.02%
2013HK$281.49 B2.61%
2012HK$274.33 B1.46%
2011HK$270.37 B-9.62%
2010HK$299.16 B18.93%
2009HK$251.55 B-28.92%
2008HK$353.90 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Takeda Pharmaceutical was reported to be:

HK$363.25 Billion
by Nasdaq info icon info icon
HK$383.95 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$3.904 T 916.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$911.36 B 137.36%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
HK$1.107 T 188.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.019 T 425.94%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
HK$335.74 B-12.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$90.71 B-76.37%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
HK$1.359 T 253.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$757.94 B 97.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$1.956 T 409.62%๐Ÿ‡บ๐Ÿ‡ธ USA